Trial reportClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026
Effect of exercise during chemotherapy infusion on symptomatology and quality of life in women with breast cancer: a randomized controlled trial.
Trial report in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the effects of aerobic exercise performed during chemotherapy infusion on symptom burden and quality of life in women with breast cancer.
methodsThis single-blind randomized controlled trial included 39 women with breast cancer undergoing chemotherapy at a specialized oncology hospital in Brazil. Participants were randomly assigned to an exercise group (n = 18) or control group (n = 21). The intervention group performed low-intensity aerobic cycling with a portable ergometer for 20 min during infusion sessions 2 through 6. Fatigue (Cancer Fatigue Scale) and quality of life (EORTC QLQ-C30) were assessed before the second and after the sixth infusion. Chemotherapy-related symptoms were also monitored via telephone recall 48-72 h post-infusion. Data were analyzed using GEE for symptom scores and repeated measures ANOVA for fatigue and quality of life outcomes.
resultsOf the 51 breast cancer patients recruited, 39 completed the study. No significant baseline differences were found between the intervention (exercise) and control groups. There were no significant changes in quality of life or fatigue scores (EORTC-QLQ-C30 and CFS) over time between groups. However, the intervention group showed a significant reduction in the severity of alopecia between chemotherapy sessions, which was not observed in the control group.
conclusionWhile exercise during chemotherapy did not significantly impact overall quality of life or fatigue, it may help reduce the perceived severity of certain treatment-related symptoms such as alopecia.
Indexed as
Identifiers
40665168What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.